Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orgasmic Meditation Effects on Parkinson's Disease
NCT05103618Phase 2Withdrawn
- Start
- Jul 2021
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (3 arms). Primary endpoints: FDOPA PET Imaging and Change in FDOPA PET Imaging. Planned start Jul 2021; status: withdrawn.
Beyond the preview
Go deeper on NCT05103618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103618.